Improving hormone receptor testing for breast cancer in Tanzania
A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania
This study is working to make hormone receptor testing for breast cancer easier and faster for women in Tanzania, so they can get the right treatment when they need it.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11001440 on NIH RePORTER |
What this research studies
This research aims to enhance the availability and efficiency of hormone receptor testing for breast cancer patients in Tanzania, where current testing capabilities are severely limited. By identifying and implementing effective strategies across public hospitals, the project seeks to ensure that more women receive timely and appropriate testing and treatment. The approach includes a formative evaluation to understand the barriers to testing and the development of a multi-faceted intervention tailored to local needs. Ultimately, the goal is to improve breast cancer care and outcomes for patients in this region.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with breast cancer in Tanzania who require hormone receptor testing.
Not a fit: Patients who are not diagnosed with breast cancer or those who have already received hormone receptor testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased access to hormone receptor testing and better treatment options for breast cancer patients in Tanzania.
How similar studies have performed: Similar research efforts in other low- and middle-income countries have shown promise in improving cancer care through enhanced testing and treatment protocols.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Ng, Dianna L. — Sloan-Kettering Inst Can Research
- Study coordinator: Ng, Dianna L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.